Never mind the hemophilia, a soccer player can still confidently bump into others while hustling downfield thanks to the Idelvion treatment, at least according to CSL Behring promotional materials, anyway.

The drug maker used such an image — specifically, a man who is about to head or kick a soccer ball while jumping high in the air — to promote its hemophilia B medication on its product website and in patient brochures, exhibit panels, and sales aids.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy